Your Notifications
All done, no notifications

Transarterial Radioembolization- TARE Cost in Switzerland

USD 55000 - USD 90000

Affordable World-class Treatment - Accredited Hospitals - Free Treatment Plan in 24 Hrs

1
Days in Hospital
60-120 min
Procedure Time
70 - 90%
Success Rate
Get Free Treatment Plan Connect with an Expert
JCI/ISO 100,000+ Patients 24X7 Coordinator Visa & Travel handled
Your all-in-one medical travel platform for treatment, recovery & care.

Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact
Connect with an Expert

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Estimated Treatment Cost
USD 55000 - USD 90000
All-inclusive • Hospital + Medications + Recovery Assistance + Dedicated Care Coordinator
International Quality. Affordable Care.

What's included in your Transarterial Radioembolization- TARE quote?

Transarterial Radioembolization (TARE)
fee, Yttrium-90 (Y-90)
Oncology team consults
Pre-evaluation, treatment planning, follow-ups
1–2-day hospital stay
management
5–7-day in-country follow-up
Value: treatment response evaluation
Visa & medical-visa invite letter
Airport pickup & transfers
Get Itemized Quote FREE

Cost of Transarterial Radioembolization- TARE in Major Cities of Switzerland

CityCost (USD)
Basel $35,000 – $60,000 Explore More

Transarterial Radioembolization Tare - Switzerland Vs the World

India
$5k - $35k
South Korea
$7k - $0
Spain
$10k - $450k
Thailand
$10k - $50k
Malaysia
$15k - $25k
Vietnam
$15k - $28k
Saudi Arabia
$20k - $35k
Turkey
$25k - $0
United Arab Emirates
$25k - $45k
United Kingdom
$25k - $45k
Israel
$30k - $45k
Singapore
$60k - $0
Nimra Haseeb
Author

Nimra Haseeb

MSc Biochemistry

4 Years of Experience

Miss Nimra Haseeb is a medical researcher and a scientific content writer. She holds a Bachelor’s degree in Biotechnology and a Master’s in Biochemistry from Integral University, Lucknow. With strong experience in healthcare research, she specializes in secondary research, clinical data analysis, and evidence-based medical writing. Her work focuses on transforming complex scientific and medical information into clear, accurate, and reliable healthcare content for patients and healthcare audiences. She is also experienced in interpreting medical studies and healthcare trends to deliver well-researched and informative content that supports better health awareness and decision-making.
View More
Dr Prateek Varshney
Reviewer

Dr Prateek Varshney

Surgical Oncologist

15 Years of Experience

Last Reviewed - June 2026

Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute.
View More

Need Help Choosing the Right Treatment? Talk to a Medical Advisor

Our dedicated Medical Patient Advisors are here to answer your questions, help you compare treatment options, estimate costs, and guide you through every step of your healthcare journey.

Connect with an Expert Request a Free Consultation
15 min
Average response time
Serving Patients Worldwide in Multiple Languages.

An advanced interventional radiology treatment is transarterial radioembolisation (TARE), also known as selective internal radiation therapy (SIRT). It is used to manage liver tumours, particularly metastases to other body regions, such as hepatocellular carcinoma (HCC). In TARE, radioactive microspheres are selectively injected into the tumour's blood vessels, achieving localised radiation and tumour necrosis.

Explore Hospitals ( 1 )

Basel, Switzerland

773+ Beds · 221+ Procedures
SAC
Starting
USD 55000

Get Your Transarterial Radioembolization- TARE
Plan in 24 hrs.

Our experienced Medical Patient Advisors have supported 100,000+ patients across 120+ countries with personalised treatment plans, hospital recommendations, cost estimates, and travel assistance, all free.

HIPAA-Compliant Data SecurityShared Only with Your Consent

✓ Free Consultation ✓ No Obligation ✓ Personalized Treatment Plan ✓ Response Within 24 Hours

Required | alphabets and spaces
Required | A valid, working email address
Required | A valid contact

Your medical info is kept HIPAA-style confidential. We never share with hospitals without your consent.

Jenny Wilson
Your Dedicated Medical Patient Advisor
Treatment planning • Hospital coordination • Multilingual support • Response within 15 minutes.
Connect with an Expert Book 15-min call
Our Services to Better your Experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Patient Stories

Ms. Monica
Ms. Monica
Monica from Ghana for AV Malformation Treatment in India

Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing…

Watch Story
Silim Shabani
Silim Shabani
Patient Testimonial: Silim Shabani for Ovarian Cancer Treatment in Turkey

Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for…

Watch Story

Frequently Asked Questions

The cost of Transarterial Radioembolization (TARE) in Switzerland may vary depending on the type and extent of the liver tumour, the number of liver segments treated, the type and dose of radioactive microspheres, pre-treatment angiography, imaging requirements, hospital charges, specialist fees, and follow-up care. The overall cost may include diagnostic imaging, liver function tests, treatment planning, mapping angiography, radioactive microsphere administration, hospitalisation, medications, and post-treatment monitoring.MediGence can help international patients explore suitable interventional oncology centres and obtain an estimated treatment plan based on the patient’s diagnosis and clinical requirements.

The best hospitals in Switzerland for TARE are those with experienced interventional radiologists, medical oncologists, hepatologists, radiation oncologists, nuclear medicine specialists, and multidisciplinary liver tumour teams. Patients should consider hospitals with advanced angiography suites, nuclear medicine facilities, specialised liver cancer programmes, and expertise in selective internal radiation therapy.

Patients should choose an interventional radiologist or interventional oncologist experienced in liver-directed therapies and radioembolization. Important factors include the specialist’s experience with hepatic artery mapping, microsphere delivery, dosimetry, management of complex liver vascular anatomy, and treatment of primary or metastatic liver tumours.The treating team should assess liver function, tumour distribution, vascular anatomy, performance status, and previous cancer treatments before recommending TARE.

Transarterial Radioembolization (TARE) has an overall success rate of approximately 40–60%, depending on the tumour type, tumour burden, liver function, treatment intent, vascular anatomy, microsphere distribution, and response to therapy. Treatment outcomes may include tumour control, reduction in tumour size, symptom improvement, or downstaging in selected patients.The treating oncology team can provide a more individualised estimate after reviewing the patient’s imaging findings, liver function, and overall clinical condition.

Hospitals in Switzerland may use digital subtraction angiography, cone-beam CT, CT or MRI, nuclear medicine imaging, technetium-99m macroaggregated albumin (99mTc-MAA) mapping, personalised dosimetry, and yttrium-90 (Y-90) microspheres.TARE involves catheter-based delivery of radioactive microspheres into tumour-feeding branches of the hepatic artery. The microspheres deliver targeted internal radiation while limiting exposure to surrounding healthy liver tissue.Depending on the patient’s condition, TARE may be used as a definitive liver-directed treatment, for tumour control, as a bridge to transplantation, or in combination with systemic therapy or other locoregional treatments.

Possible risks and complications may include:
  • Fatigue, nausea, abdominal discomfort, or low-grade fever
  • Post-radioembolization syndrome
  • Temporary elevation of liver enzymes
  • Liver dysfunction or radiation-induced liver injury
  • Damage to non-target organs due to unintended microsphere delivery
  • Gastrointestinal ulceration or bleeding
  • Radiation pneumonitis in rare cases
  • Bile duct injury or gallbladder inflammation
  • Bleeding, infection, or vascular complications at the catheter entry site
  • Allergic or kidney-related complications from contrast material
  • Need for additional cancer treatment
    • The treating team will explain the potential risks based on the patient’s liver function, tumour characteristics, and planned treatment.

    Patients should share all relevant medical records with the treating oncology team before travelling. These may include CT or MRI scans, PET-CT reports when available, pathology reports, previous treatment records, liver function tests, blood counts, coagulation reports, kidney function tests, and information about current medications and allergies.Patients should also discuss the treatment timeline, pre-treatment mapping procedure, hospital stay, radiation safety instructions, follow-up imaging, and post-treatment monitoring before making travel arrangements.

    Yes. International patients can arrange an online consultation with an interventional radiologist, medical oncologist, or liver cancer specialist before travelling to Switzerland. The specialist may review tumour imaging, pathology findings, liver function, previous treatments, and overall health to determine whether TARE may be appropriate.MediGence can help coordinate online consultations and facilitate the sharing of relevant medical records with suitable specialists.

    International patients should carry a valid passport and relevant medical documents, including:
  • Recent liver CT, MRI, or PET-CT reports and images
  • Tumour biopsy or pathology reports
  • Previous oncology treatment records
  • Liver and kidney function test results
  • Complete blood count and coagulation reports
  • Previous angiography or interventional procedure records
  • Current prescriptions and medication details
  • Allergy and medical history records

    • The required stay in Switzerland depends on the treatment protocol, pre-treatment mapping, number of liver areas treated, and the patient’s recovery. TARE commonly involves a planning angiogram followed by the radioembolization procedure, which may be performed on separate days.Patients may need to remain in Switzerland for post-treatment observation, clinical assessment, and early follow-up. The treating team will recommend an appropriate stay based on the treatment plan and the patient’s clinical condition.

    Recovery after TARE is generally shorter than after open surgery, although fatigue, reduced appetite, nausea, or abdominal discomfort may occur for several days or weeks. Most patients can gradually resume routine activities based on their clinical condition and the treating team’s advice.Follow-up blood tests and imaging are required to assess liver function, treatment response, and possible complications.

    If complications occur, patients should contact the treating oncology or interventional radiology team or seek prompt medical attention. Urgent evaluation may be required for severe abdominal pain, persistent vomiting, high fever, jaundice, gastrointestinal bleeding, breathing difficulty, increasing abdominal swelling, confusion, or sudden worsening of symptoms.Patients should receive clear discharge instructions and a detailed follow-up plan before returning home.

    International patients can submit their medical details and relevant cancer imaging through the MediGence website. Following an initial review, the MediGence care team can help patients explore suitable hospitals and experienced interventional oncology specialists, coordinate consultations, and support treatment and medical travel planning.The final treatment recommendation is made by the multidisciplinary oncology team after a detailed clinical evaluation.

    International patients may choose Switzerland for access to experienced interventional radiologists, specialised liver cancer programmes, advanced angiography and nuclear medicine facilities, personalised radiation dosimetry, and multidisciplinary oncology care. The destination should be evaluated based on clinical expertise, treatment infrastructure, patient safety standards, and availability of follow-up services.

    Treatment options depend on the tumour type, number and location of liver lesions, liver function, vascular anatomy, disease stage, and previous treatments. Options may include:
  • Systemic therapy, including targeted therapy or immunotherapy
  • Surgical liver resection
  • Liver transplantation in eligible patients
  • Thermal ablation
  • Transarterial chemoembolization (TACE)
  • Transarterial Radioembolization (TARE) using Y-90 microspheres
  • External beam radiation therapy
  • Combination treatment with systemic or locoregional therapies
  • Supportive and symptom-directed care
    • The multidisciplinary oncology team will recommend the most appropriate treatment after reviewing the patient’s diagnosis, imaging findings, liver function, and overall clinical condition.

    International patients may choose Switzerland for access to specialised interventional oncology centres, experienced liver cancer specialists, advanced Y-90 radioembolization technology, personalised treatment planning, and comprehensive oncology support.MediGence can assist with hospital and specialist selection, medical record coordination, consultation scheduling, treatment planning, and travel-related support. The final destination should be selected according to the patient’s cancer type, liver function, treatment requirements, and the hospital’s expertise in TARE.

    Not Sure About Your Treatment Plan? Get a Free Second Opinion

    Have your reports reviewed by independent oncology experts to help you make a confident treatment decision, all online within 48 hours.

    Upload Your Reports
    Free second opinion on your CAR-T plan